Sharp Therapeutics Corp.
SHRXF
$3.00
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 130.97% | -164.60% | 88.01% | 88.01% | -114.23% |
| Total Depreciation and Amortization | 177.11% | -36.26% | -4.96% | -4.96% | -73.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -397.03% | 218.69% | -333.37% | -333.37% | 134.59% |
| Change in Net Operating Assets | -94.67% | -323.89% | -412.18% | -412.18% | 2,695.15% |
| Cash from Operations | -98.25% | -132.03% | -154.18% | -154.18% | -31.72% |
| Capital Expenditure | -- | -- | -- | -- | 419.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 419.23% |
| Total Debt Issued | -- | -- | 174.09% | 174.09% | 94.98% |
| Total Debt Repaid | 0.00% | 0.00% | -236.80% | -236.80% | 0.00% |
| Issuance of Common Stock | -- | -- | 108.35% | 108.35% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 102.68% | -111.11% | 460.60% | 460.60% | 102.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,873.49% | -710.71% | 4,611.30% | 4,611.30% | -46.94% |